東和薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2001/08/17 | 546.7 | 550 | 546.7 | 550 | ±0 | ±0% | 6,000 |
2001/08/16 | 550 | 550 | 546.7 | 550 | +3.3 | +0.6% | 63,000 |
2001/08/15 | 546.7 | 546.7 | 546.7 | 546.7 | ±0 | ±0% | 30,000 |
2001/08/14 | 546.7 | 546.7 | 546.7 | 546.7 | ±0 | ±0% | 6,000 |
2001/08/13 | 543.3 | 546.7 | 543.3 | 546.7 | ±0 | ±0% | 39,000 |
2001/08/10 | 540 | 546.7 | 536.7 | 546.7 | +3.4 | +0.6% | 123,000 |
2001/08/09 | 533.3 | 543.3 | 533.3 | 543.3 | ±0 | ±0% | 66,000 |
2001/08/08 | 533.3 | 546.7 | 533.3 | 543.3 | +13.3 | +2.5% | 159,000 |
2001/08/07 | 523.3 | 530 | 523.3 | 530 | +3.3 | +0.6% | 147,000 |
2001/08/06 | 523.3 | 526.7 | 520 | 526.7 | +3.4 | +0.6% | 48,000 |
2001/08/03 | 533.3 | 550 | 510 | 523.3 | -6.7 | -1.3% | 342,000 |
2001/08/02 | 516.7 | 536.7 | 506.7 | 530 | +16.7 | +3.3% | 132,000 |
2001/08/01 | 513.3 | 520 | 503.3 | 513.3 | -3.4 | -0.7% | 66,000 |
2001/07/31 | 510 | 516.7 | 506.7 | 516.7 | -3.3 | -0.6% | 24,000 |
2001/07/30 | 530 | 530 | 510 | 520 | -13.3 | -2.5% | 45,000 |
2001/07/27 | 533.3 | 543.3 | 516.7 | 533.3 | ±0 | ±0% | 204,000 |
2001/07/26 | 466.7 | 533.3 | 466.7 | 533.3 | +66.6 | +14.3% | 330,000 |
2001/07/25 | 460 | 466.7 | 456.7 | 466.7 | +6.7 | +1.5% | 96,000 |
2001/07/24 | 463.3 | 463.3 | 456.7 | 460 | -3.3 | -0.7% | 24,000 |
2001/07/23 | 473.3 | 473.3 | 460 | 463.3 | -6.7 | -1.4% | 18,000 |
2001/07/19 | 463.3 | 470 | 463.3 | 470 | +6.7 | +1.4% | 54,000 |
2001/07/18 | 460 | 466.7 | 460 | 463.3 | +10 | +2.2% | 24,000 |
2001/07/17 | 453.3 | 453.3 | 450 | 453.3 | ±0 | ±0% | 18,000 |
2001/07/16 | 470 | 470 | 436.7 | 453.3 | -13.4 | -2.9% | 150,000 |
2001/07/13 | 466.7 | 466.7 | 466.7 | 466.7 | -6.6 | -1.4% | 9,000 |
2001/07/12 | 473.3 | 473.3 | 466.7 | 473.3 | - | - | 24,000 |
2001/07/11 | 0 | 0 | 0 | 0 | - | - | 0 |
2001/07/10 | 466.7 | 470 | 460 | 470 | -3.3 | -0.7% | 45,000 |
2001/07/09 | 476.7 | 483.3 | 470 | 473.3 | -13.4 | -2.8% | 24,000 |
2001/07/06 | 490 | 490 | 483.3 | 486.7 | -6.6 | -1.3% | 132,000 |
2001/07/05 | 496.7 | 496.7 | 493.3 | 493.3 | ±0 | ±0% | 63,000 |
2001/07/04 | 476.7 | 496.7 | 473.3 | 493.3 | +20 | +4.2% | 423,000 |
2001/07/03 | 466.7 | 473.3 | 463.3 | 473.3 | +6.6 | +1.4% | 63,000 |
2001/07/02 | 466.7 | 466.7 | 463.3 | 466.7 | +3.4 | +0.7% | 75,000 |
2001/06/29 | 460 | 463.3 | 456.7 | 463.3 | +3.3 | +0.7% | 51,000 |
2001/06/28 | 456.7 | 460 | 456.7 | 460 | ±0 | ±0% | 81,000 |
2001/06/27 | 456.7 | 460 | 456.7 | 460 | +3.3 | +0.7% | 21,000 |
2001/06/26 | 456.7 | 456.7 | 453.3 | 456.7 | ±0 | ±0% | 75,000 |
2001/06/25 | 453.3 | 460 | 453.3 | 456.7 | +6.7 | +1.5% | 276,000 |
2001/06/22 | 443.3 | 453.3 | 440 | 450 | +10 | +2.3% | 153,000 |
2001/06/21 | 423.3 | 443.3 | 423.3 | 440 | +16.7 | +3.9% | 360,000 |
2001/06/20 | 406.7 | 423.3 | 406.7 | 423.3 | +16.6 | +4.1% | 135,000 |
2001/06/19 | 406.7 | 406.7 | 406.7 | 406.7 | -3.3 | -0.8% | 6,000 |
2001/06/18 | 423.3 | 423.3 | 406.7 | 410 | -10 | -2.4% | 51,000 |
2001/06/15 | 400 | 423.3 | 400 | 420 | +16.7 | +4.1% | 174,000 |
2001/06/14 | 403.3 | 403.3 | 403.3 | 403.3 | ±0 | ±0% | 18,000 |
2001/06/13 | 400 | 403.3 | 400 | 403.3 | +3.3 | +0.8% | 12,000 |
2001/06/12 | 410 | 410 | 400 | 400 | -6.7 | -1.6% | 45,000 |
2001/06/11 | 406.7 | 406.7 | 406.7 | 406.7 | +3.4 | +0.8% | 3,000 |
2001/06/08 | 403.3 | 403.3 | 403.3 | 403.3 | +3.3 | +0.8% | 27,000 |
5701~
5750
件表示中 / 6839件
類似銘柄と比較する
現在ご覧いただいている「東和薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
東和薬品 | 282,000円 | +15.0% | -7.3% | 2.13% | 9.25倍 | 0.87倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
科研薬 | 446,100円 | +22.8% | +113.0% | 4.26% | 11.90倍 | 1.09倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
キッセイ薬 | 365,500円 | +14.5% | -2.3% | 2.46% | 13.37倍 | 0.71倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
市場注目の銘柄
チャート関連のコラム